Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The cytokines HGF and CXCL13 predict the severity and the mortality in COVID-19 patients
Matthieu Perreau, Madeleine Suffiotti, Pedro Marques‐Vidal, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 108

Showing 1-25 of 108 citing articles:

Pulmonary Fibrosis as a Result of Acute Lung Inflammation: Molecular Mechanisms, Relevant In Vivo Models, Prognostic and Therapeutic Approaches
Innokenty A. Savin, Marina A. Zenkova, Aleksandra V. Sen’kova
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 14959-14959
Open Access | Times Cited: 125
Severe Neuro-COVID is associated with peripheral immune signatures, autoimmunity and neurodegeneration: a prospective cross-sectional study
Manina M. Etter, Tomás A. Martins, Laila Kulsvehagen, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 77
Distinct type 1 immune networks underlie the severity of restrictive lung disease after COVID-19
Glenda Canderan, Lyndsey M. Muehling, Alexandra Kadl, et al.
Nature Immunology (2025)
Open Access | Times Cited: 2
CytoSorb Rescue for COVID-19 Patients With Vasoplegic Shock and Multiple Organ Failure: A Prospective, Open-Label, Randomized Controlled Pilot Study*
Helena Stockmann, Philipp Thelen, Fabian Stroben, et al.
Critical Care Medicine (2022) Vol. 50, Iss. 6, pp. 964-976
Open Access | Times Cited: 60
Intranasal administration of BReC-CoV-2 COVID-19 vaccine protects K18-hACE2 mice against lethal SARS-CoV-2 challenge
Ting Y. Wong, Katherine S. Lee, Brynnan P. Russ, et al.
npj Vaccines (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 46
Consecutive BNT162b2 mRNA vaccination induces short-term epigenetic memory in innate immune cells
Yuta Yamaguchi, Yasuhiro Kato, Ryuya Edahiro, et al.
JCI Insight (2022) Vol. 7, Iss. 22
Open Access | Times Cited: 39
Targeted plasma proteomics reveals signatures discriminating COVID-19 from sepsis with pneumonia
Laura M. Palma Medina, Haris Babačić, Majda Dzidic, et al.
Respiratory Research (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 27
Para-infectious brain injury in COVID-19 persists at follow-up despite attenuated cytokine and autoantibody responses
Benedict Michael, Cordelia Dunai, Edward Needham, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 23
SARS-CoV-2 infection- induced growth factors play differential roles in COVID-19 pathogenesis
Anamika Gupta, Manju Nidagodu Jayakumar, Mohamed A. Saleh, et al.
Life Sciences (2022) Vol. 304, pp. 120703-120703
Open Access | Times Cited: 38
The Interaction Between Pulmonary Fibrosis and COVID-19 and the Application of Related Anti-Fibrotic Drugs
Hao Shen, Nu Zhang, Yuqing Liu, et al.
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 33
Comparison of C-reactive protein with distinct hyperinflammatory biomarkers in association with COVID-19 severity, mortality and SARS-CoV-2 variants
Tudorița Gabriela Părângă, Mariana Pavel, Daniela Constantinescu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 23
Kaempferol has potential anti‐coronavirus disease 2019 (COVID‐19) targets based on bioinformatics analyses and pharmacological effects on endotoxin‐induced cytokine storm
Yaoxiang Sun, Qing Tao, Yang Cao, et al.
Phytotherapy Research (2023) Vol. 37, Iss. 6, pp. 2290-2304
Closed Access | Times Cited: 19
Deep spatial proteomics reveals region-specific features of severe COVID-19-related pulmonary injury
Yiheng Mao, Ying Chen, Yuan Li, et al.
Cell Reports (2024) Vol. 43, Iss. 2, pp. 113689-113689
Open Access | Times Cited: 8
Multi-cohort study on cytokine and chemokine profiles in the progression of COVID-19
Chaolin Huang, Xujuan Hu, Delong Wang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 7
Role of SARS-CoV-2 -induced cytokines and growth factors in coagulopathy and thromboembolism
Firdos Ahmad, Meganathan Kannan, Abdul W. Ansari
Cytokine & Growth Factor Reviews (2021) Vol. 63, pp. 58-68
Open Access | Times Cited: 37
Serum biomarkers associated with SARS-CoV-2 severity
Fabiani de Morais Batista, Marco Antonio Moreira Puga, Patrícia Vieira da Silva, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 23
Serum cytokine dysregulation signatures associated with COVID-19 outcomes in high mortality intensive care unit cohorts across pandemic waves and variants
Henrike Maaß, Mario Alberto Ynga-Durand, Marko Milošević, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 6
Changes in chemokine and growth factor levels may be useful biomarkers for monitoring disease severity in COVID-19 patients; a pilot study
Blanka Wolszczak-Biedrzycka, Justyna Dorf, Marzena Wojewódzka‐Żeleźniakowicz, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 5
Primary prophylaxis with mTOR inhibitor enhances T cell effector function and prevents heart transplant rejection during talimogene laherparepvec therapy of squamous cell carcinoma
Victor Joo, Karim Abdelhamid, Alessandra Noto, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 5
Predictive biomarkers of mortality in patients with severe COVID-19 hospitalized in intensive care unit
Sandrelli Meridiana de Fátima Ramos dos Santos Medeiros, Bruna Maria Nepomuceno Sousa Lino, Vinícius Pietta Perez, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
Considerations for Novel COVID-19 Mucosal Vaccine Development
Wael Alturaiki
Vaccines (2022) Vol. 10, Iss. 8, pp. 1173-1173
Open Access | Times Cited: 20
Plasma Apolipoprotein Concentrations Are Highly Altered in Severe Intensive Care Unit COVID-19 Patients: Preliminary Results from the LIPICOR Cohort Study
Floran Bègue, Kévin Chemello, Bryan Veeren, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4605-4605
Open Access | Times Cited: 12
Predictive biomarkers of COVID-19 prognosis identified in Bangladesh patients and validated in Japanese cohorts
Kazuko Uno, A. R. Hasan, Emi E. Nakayama, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 4
The Cytokine Storm in COVID-19: The Strongest Link to Morbidity and Mortality in the Current Epidemic
Maamoun Basheer, Elias Saad, Nimer Assy
COVID (2022) Vol. 2, Iss. 5, pp. 540-552
Open Access | Times Cited: 19
CytoSorb in patients with coronavirus disease 2019: A rapid evidence review and meta-analysis
Shilin Wei, Yanchun Zhang, Kerong Zhai, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top